Sex and Age Influence the Relationship Between Serum Creatinine/Cystatin C and Carotid Plaque in Patients With Type 2 Diabetes Mellitus

被引:1
|
作者
Yang, Dan [2 ]
Li, Kexin [2 ]
Zhang, Qiujuan [1 ]
Yu, Tian [1 ]
Liu, Ling [4 ]
Wang, You [3 ]
Kang, Shuyuan [3 ]
Song, Shumiao [3 ]
Xu, Baofeng [3 ]
Liu, Rui [1 ,5 ]
机构
[1] Jilin Univ, China Japan Union Hosp, 126 Xiantaii St, Changchun, Peoples R China
[2] Jilin Prov Peoples Hosp, Changchun, Peoples R China
[3] First Hosp Jilin Univ, Changchun, Peoples R China
[4] Jilin Univ, Sch Basic Med Sci, Changchun, Peoples R China
[5] Changsha Med Univ, 1501 Leifeng St, Changsha 410203, Hunan, Peoples R China
关键词
type; 2; diabetes; sex; age; serum creatinine/cystatin C ratio; carotid atherosclerosis; carotid plaque; MUSCLE MASS; DEVELOPMENTAL ORIGINS; RISK-FACTORS; CYSTATIN C; ATHEROSCLEROSIS; PREVALENCE; SARCOPENIA;
D O I
10.1177/00033197241280527
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We investigated the effect of sex and age on the association between serum creatinine/cystatin C (CCR) ratio and carotid plaque in patients with type 2 diabetes mellitus (T2DM). The carotid plaque group and the non-plaque group were divided according to cervical vascular ultrasound; the general and biochemical data of the two groups were compared according to CCR, gender, and age. Binary logistic regression was used to analyze the factors influencing carotid plaque. A total of 1429 patients with T2DM were included in this study. On multivariate analysis, CCR was an independent predictor of carotid plaque with an adjusted odds ratio (OR) of 1.681 [1.250-2.260]. The risk of carotid plaque in men with T2DM increased significantly (P < .05) with decreasing levels of CCR. In addition, an association between CCR and carotid plaque was found in individuals with T2DM <65 years of age (P < .05). CCR is strongly associated with the risk of carotid plaques in persons with T2DM and are an independent risk factor for carotid plaques in men and people aged <65 years with T2DM.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] CORRELATION BETWEEN CYSTATIN C AND RETINOPATHY OF TYPE- TWO DIABETES MELLITUS PATIENTS
    Qian, C.
    Wan, G. M.
    Yan, P. S.
    Wang, W. Z.
    Liang, S. Z.
    Dong, Y.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2017, 31 (01): : 99 - 103
  • [42] Analysis of the relationship between serum creatinine/cystatin C ratio and muscle mass in patients with hepatocellular carcinoma
    Oura, Hirotaka
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Kobayashi, Kazufumi
    Maruta, Susumu
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Maeda, Takahiro
    Kusakabe, Yuko
    Kiyono, Soichiro
    Nakamura, Masato
    Saito, Tomoko
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Yasui, Shin
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Naoya
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E844 - E844
  • [43] Serum cystatin C levels are decreased in type 1 diabetes mellitus patients with diabetic ketoacidosis
    Cheng, Yiping
    Xu, Chao
    Wang, Sichao
    Hou, Lin
    Guan, Qingbo
    Zhou, Xinli
    MINERVA ENDOCRINOLOGICA, 2020, 45 (02) : 106 - 116
  • [44] Sex Difference in the Association Between Serum Versican and Albuminuria in Patients with Type 2 Diabetes Mellitus
    Li, Shuang
    Li, Niman
    Li, Linsen
    Zhan, Junkun
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 3631 - 3639
  • [45] Fenofibrate but not sirinvastatin increases serum homocysteine and creatinine in patients with type 2 diabetes mellitus
    Stulc, T
    Malik, J
    Ceska, R
    Kozich, V
    Skrha, J
    CIRCULATION, 2003, 108 (17) : 719 - 719
  • [46] Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes
    Osaka, Takafumi
    Hamaguchi, Masahide
    Hashimoto, Yoshitaka
    Ushigome, Emi
    Tanaka, Muhei
    Yamazaki, Masahiro
    Fukui, Michiaki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 139 : 52 - 58
  • [47] Fenofibrate but not simvastatin increases serum homocysteine and creatinine in patients with type 2 diabetes mellitus
    Stulc, T
    Ceska, R
    Kozich, V
    Skrha, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 120 - 120
  • [48] Diagnostic Accuracy of Serum Cystatin C for Early Recognition of Nephropathy in Type 2 Diabetes Mellitus
    Sapkota, Suman
    Khatiwada, Saroj
    Shrestha, Shrijana
    Baral, Nirmal
    Maskey, Robin
    Majhi, Shankar
    Chandra, Lal
    Lamsal, Madhab
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2021, 2021
  • [49] Association between Cardiovascular Autonomic Neuropathy and Cystatin C in Type 2 Diabetes Mellitus
    Lee, Hong Seok
    Ban, Woo Ho
    Kim, Yeon Ji
    Kim, Bo Kyung
    Ha, Won Chul
    Oh, Su Jin
    Son, Hyun Shik
    Sohn, Tae Seo
    DIABETES, 2013, 62 : A153 - A153
  • [50] Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus
    Elsayed, Mohamed Shawky
    El Badawy, Ayman
    Ahmed, Abdelmon'em
    Omar, Rasha
    Mohamed, Amr
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 374 - 381